Prescription Drug Monitoring Programs
"Prescription Drug Monitoring Programs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.
Descriptor ID |
D000073958
|
MeSH Number(s) |
E05.337.800.800 N02.421.668.320.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drug Monitoring Programs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Monitoring Programs".
This graph shows the total number of publications written about "Prescription Drug Monitoring Programs" by people in this website by year, and whether "Prescription Drug Monitoring Programs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 2 | 0 | 2 |
2018 | 4 | 0 | 4 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Prescription Drug Monitoring Programs" by people in Profiles.
-
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020. JAMA Intern Med. 2020 10 01; 180(10):1384-1386.
-
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008.
-
HIV postexposure prophylaxis during COVID-19. Lancet HIV. 2020 07; 7(7):e460.
-
On Call at the Capitol: TMA's 2019 Legislative Agenda. Tex Med. 2019 Jan 01; 115(1):20-25.
-
A standardized methodology for the surveillance of antimicrobial prescribing linked to clinical indications in primary care. J Public Health (Oxf). 2018 09 01; 40(3):630-638.
-
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. Health Aff (Millwood). 2018 06; 37(6):964-974.
-
Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):422-429.
-
Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing. Implement Sci. 2018 02 26; 13(1):37.
-
Prescription drug monitoring program design and function: A qualitative analysis. Drug Alcohol Depend. 2017 11 01; 180:395-400.
-
Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States. Addiction. 2017 Oct; 112(10):1784-1796.